Trillium Therapeutics Inc. Soared

Thu, Jan 23, 2020 at 05:30 PM
Trillium Therapeutics Inc. Soared

Trillium Therapeutics Inc. (TRIL:NASDAQ) shot up at $4.22, representing a gain of 29.2%. On Wed 22 Jan 20, TRIL:NASDAQ touched a New 2-Week High of $3.27. The stock got featured on our News Catalysts scanner on Thu 23 Jan 20 at 09:36 AM in the 'PUBLIC OFFERING' category. From Tue 31 Dec 19, the stock recorded 50.00% Up Days and 46.67% Green Days

The share price of the company has been moving sideways in recent weeks.

About Trillium Therapeutics Inc. (TRIL:NASDAQ)

Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of cancer. Its SIRPaFc and CD200 monoclonal antibody targets immuno regulatory pathways that tumor cells exploit to evade the host immune system.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.